» Articles » PMID: 25981960

Longitudinal Changes in Free-water Within the Substantia Nigra of Parkinson's Disease

Overview
Journal Brain
Specialty Neurology
Date 2015 May 19
PMID 25981960
Citations 116
Authors
Affiliations
Soon will be listed here.
Abstract

There is a clear need to develop non-invasive markers of substantia nigra progression in Parkinson's disease. We previously found elevated free-water levels in the substantia nigra for patients with Parkinson's disease compared with controls in single-site and multi-site cohorts. Here, we test the hypotheses that free-water levels in the substantia nigra of Parkinson's disease increase following 1 year of progression, and that baseline free-water levels in the substantia nigra predict the change in bradykinesia following 1 year. We conducted a longitudinal study in controls (n = 19) and patients with Parkinson's disease (n = 25). Diffusion imaging and clinical data were collected at baseline and after 1 year. Free-water analyses were performed on diffusion imaging data using blinded, hand-drawn regions of interest in the posterior substantia nigra. A group effect indicated free-water values were increased in the posterior substantia nigra of patients with Parkinson's disease compared with controls (P = 0.003) and we observed a significant group × time interaction (P < 0.05). Free-water values increased for the Parkinson's disease group after 1 year (P = 0.006), whereas control free-water values did not change. Baseline free-water values predicted the 1 year change in bradykinesia scores (r = 0.74, P < 0.001) and 1 year change in Montreal Cognitive Assessment scores (r = -0.44, P = 0.03). Free-water in the posterior substantia nigra is elevated in Parkinson's disease, increases with progression of Parkinson's disease, and predicts subsequent changes in bradykinesia and cognitive status over 1 year. These findings demonstrate that free-water provides a potential non-invasive progression marker of the substantia nigra.

Citing Articles

Analysis of Two Neuroanatomical Subtypes of Parkinson's Disease and Their Motor Progression Based on Semi-Supervised Machine Learning.

Zhou H, Wu Y, Chen S, Xing Y, Ren J, Liu W CNS Neurosci Ther. 2025; 31(2):e70277.

PMID: 39953811 PMC: 11829112. DOI: 10.1111/cns.70277.


Mapping the aging brain: Insights into microstructural changes from free water-corrected fractional anisotropy.

Bower A, Chung J, Burciu R Neurosci Lett. 2025; 849:138120.

PMID: 39862921 PMC: 11851011. DOI: 10.1016/j.neulet.2025.138120.


Assessment of complementary white matter microstructural changes and grey matter atrophy in the 6-OHDA-induced model of Parkinson's disease.

Bergamino M, Fuentes A, Sandoval I, Marmion D, Bishop C, Manfredsson F Neuroscience. 2025; 568:2-11.

PMID: 39800048 PMC: 11871993. DOI: 10.1016/j.neuroscience.2025.01.019.


Functional and free-water imaging in rapid eye movement behaviour disorder and Parkinson's disease.

Tobin E, Arpin D, Schauder M, Higgonbottham M, Chen R, Lou X Brain Commun. 2024; 6(5):fcae344.

PMID: 39411244 PMC: 11474242. DOI: 10.1093/braincomms/fcae344.


Longitudinal evaluation of structural brain alterations in two established mouse models of Gulf War Illness.

Carpenter J, Hughes S, Filipov N Front Neurosci. 2024; 18:1465701.

PMID: 39308947 PMC: 11412963. DOI: 10.3389/fnins.2024.1465701.


References
1.
Schwarz S, Abaei M, Gontu V, Morgan P, Bajaj N, Auer D . Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis. Neuroimage Clin. 2013; 3:481-8. PMC: 3830065. DOI: 10.1016/j.nicl.2013.10.006. View

2.
Ziegler E, Rouillard M, Andre E, Coolen T, Stender J, Balteau E . Mapping track density changes in nigrostriatal and extranigral pathways in Parkinson's disease. Neuroimage. 2014; 99:498-508. PMC: 4121087. DOI: 10.1016/j.neuroimage.2014.06.033. View

3.
Mandl R, Schnack H, Zwiers M, van der Schaaf A, Kahn R, Hulshoff Pol H . Functional diffusion tensor imaging: measuring task-related fractional anisotropy changes in the human brain along white matter tracts. PLoS One. 2008; 3(11):e3631. PMC: 2574009. DOI: 10.1371/journal.pone.0003631. View

4.
Kwon D, Kim J, Oh S, Jeong H, Park S, Oh E . Seven-Tesla magnetic resonance images of the substantia nigra in Parkinson disease. Ann Neurol. 2012; 71(2):267-77. DOI: 10.1002/ana.22592. View

5.
Du G, Lewis M, Styner M, Shaffer M, Sen S, Yang Q . Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease. Mov Disord. 2011; 26(9):1627-32. PMC: 3154471. DOI: 10.1002/mds.23643. View